Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues

Bioorganic & Medicinal Chemistry Letters
Yasinalli TamboliAlberto Gasco

Abstract

We describe a new class of NO-donor hypoglycemic products obtained by joining tolbutamide, a typical hypoglycemic sulfonylurea, with a NO-donor moiety through a hard link. As NO-donors we chose either furoxan (1,2,5-oxadiazole 2-oxide) derivatives or the classical nitrooxy function. A preliminary biological characterization of these compounds, including stimulation of insulin release from cultured rat pancreatic β-cells and in vitro vasodilator and anti-aggregatory activities, is reported.

References

Dec 12, 2002·Diabetes·Peter ProksFrances Ashcroft
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic

❮ Previous
Next ❯

Related Concepts

Related Feeds